Asthma is a disease of airway inflammation, and patients with severe or refractory asthma suffer from frequent exacerbations despite being on high doses of glucocorticoid (GC). Vitamin D (vit D) is used in psoriasis as a steroid sparing agent and inhibits chemokine secretion from keratinocytes in vitro. We have shown that administration of vit D to airway smooth muscle (ASM) cells inhibits inflammatory cytokine induced chemokine secretion and preliminary data suggests that treating ASM with a combination of GC and vit D has additive effects on inhibition of chemokine secretion from inflammatory cytokine stimulated ASM. We postulate that nuclear receptor activation using vit D decreases inflammatory gene expression in ASM by modulating glucocorticoid receptor and/or transcription factor expression. To test these hypotheses, in Aim 1, the role of vit D and glucocorticoid (GC) in mediating cytokine induced chemokine release from ASM will be determined by treating ASM with vit D and/or GC prior to stimulation with cytokines, then assessing chemokine release in steroid sensitive and insensitive states by quantitative methods to determine if vit D inhibits steroid insensitive chemokine secretion from ASM or works as a steroid sparing agent.
In Aim 2 we will determine whether the additive effects of GC and vit D on chemokine secretion from cytokine stimulated ASM require augmentation of GR activation. This will involve assessing affects of vit D administration on GC induced GR translocation, DNA binding, and gene transcription.
In Aim 3, vit D interaction with transcription factors NFkB and AP-1 will be assessed in ASM treated with vit D and inflammatory cytokines.

Public Health Relevance

These studies will identify the mechanisms by which vit D inhibits steroid sensitive and steroid insensitive chemokine secretion from ASM and provide insight into new therapeutic targets to decrease asthma morbidity and prevent exacerbations.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32HL096286-01
Application #
7676938
Study Section
Special Emphasis Panel (ZRG1-F10-H (21))
Program Officer
Rothgeb, Ann E
Project Start
2009-08-01
Project End
2010-04-30
Budget Start
2009-08-01
Budget End
2010-04-30
Support Year
1
Fiscal Year
2009
Total Cost
$46,514
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Banerjee, Audreesh; Trivedi, Chinmay M; Damera, Gautam et al. (2012) Trichostatin A abrogates airway constriction, but not inflammation, in murine and human asthma models. Am J Respir Cell Mol Biol 46:132-8